Compare McKesson Corporation (MCK) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs iShares 0 3 Month Treasury Bond ETF — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while iShares 0 3 Month Treasury Bond ETF trades at $100.66. The key difference: McKesson Corporation pays a 0.39% dividend while iShares 0 3 Month Treasury Bond ETF pays none, and iShares 0 3 Month Treasury Bond ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| MCK | SGOV | |
|---|---|---|
Market Cap | $97.35B | — |
Sector | Health | Fixed Income |
52-Week High | $995.69 | $100.74 |
52-Week Low | $659.01 | $100.28 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.59 with minimal daily movement, reflecting its stable nature as a short-term Treasury vehicle. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. The ETF continues to attract institutional interest as investors seek yield and stability amid rate uncertainty, with recent articles highlighting its role in cash management strategies.
SGOV offers investors a low-risk cash alternative with competitive yields around 3.5-3.6%, though its performance remains highly sensitive to Federal Reserve policy decisions. The primary risk involves potential rate hikes that could pressure short-term bond values, while the opportunity lies in providing liquidity and income in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
